# Characterization of Cannabis Cultivars Using Public Testing Data – Labroots > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-cultivar-chemical-profiles-standardization/ > **Published:** 2026-03-22T13:01:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:42:02-04:00 > **Clinical Summary:** Explore cannabis cultivar chemical profiles using public testing data to improve standardization and therapeutic decision-making in cannabis medicine. --- ✦ New CED Clinical Relevance  #86High Clinical Relevance  Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News  |  CED Clinic StandardizationLaboratory TestingCannabinoidsTerpenes[Clinical Research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) Why This Matters Public testing data analysis could help standardize cannabis cultivar characterization, moving beyond marketing names to chemical profiles that actually inform therapeutic decisions. This matters because patients often choose products based on strain names that may have little correlation with actual cannabinoid and terpene content. Clinical Summary This research examines publicly available laboratory testing data to characterize cannabis cultivars based on their actual chemical composition rather than traditional strain classifications. The analysis likely focuses on cannabinoid profiles, terpene patterns, and other measurable compounds across different named varieties. Such systematic characterization could help identify which chemical profiles correlate with specific therapeutic effects, though the study’s methodology and findings require careful evaluation of data quality and laboratory standardization. Dr. Caplan’s Take “We desperately need chemical standardization in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) — too many patients are choosing products based on strain names that tell us nothing about therapeutic potential. If this analysis can move us toward chemical phenotyping over marketing phenotyping, it’s clinically valuable.” Clinical Perspective 🧠 Clinicians should remain skeptical of strain-based recommendations until we have robust chemical characterization data. Focus on cannabinoid ratios and terpene profiles when available rather than cultivar names. This type of research may eventually provide the chemical standardization necessary for evidence-based cannabis prescribing. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Characterization%20of%20Cannabis%20Cultivars%20Using%20Public%20Testing%20Data%20-%20Labroots%20%40drcaplan&url=https%3A//www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Characterization%20of%20Cannabis%20Cultivars%20Using%20Public%20Testing%20Data%20-%20Labroots%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data](https://www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What aspects of cannabis are covered in this research?](#What_aspects_of_cannabis_are_covered_in_this_research) - [Why is laboratory testing important for medical cannabis?](#Why_is_laboratory_testing_important_for_medical_cannabis) - [How does standardization benefit cannabis patients?](#How_does_standardization_benefit_cannabis_patients) - [What role do terpenes play in cannabis medicine?](#What_role_do_terpenes_play_in_cannabis_medicine) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This article has been assigned a “High Clinical Relevance” rating (#86) by CED. This indicates strong evidence or policy relevance with direct clinical implications for healthcare practice. #### What aspects of cannabis are covered in this research? The research focuses on standardization, laboratory testing, cannabinoids, and terpenes. These are key areas for understanding cannabis quality, safety, and therapeutic potential. #### Why is laboratory testing important for medical cannabis? Laboratory testing ensures product safety, potency, and consistency for patients. It helps identify contaminants, verify cannabinoid and terpene profiles, and supports standardized dosing recommendations. #### How does standardization benefit cannabis patients? Standardization provides predictable and consistent therapeutic effects across different products and batches. This allows for more reliable dosing and better treatment outcomes for [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) patients. #### What role do terpenes play in cannabis medicine? Terpenes are aromatic compounds that may influence the therapeutic effects of cannabis through the “entourage effect.” They can potentially modify [how cannabinoids work](https://cedclinic.com/cannabinoids-neuromuscular-communication-benefits/) and contribute to strain-specific effects. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Characterization of Cannabis Cultivars Using Public Testing Data – Labroots”, “url”: “https://www.labroots.com/zh/webinar/characterization-cannabis-cultivars-using-public-testing-data”, “datePublished”: “2026-03-22T11:16:30Z”, “about”: “characterization cannabis cultivars using public testing”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabinoids for Anxiety & Tourette's: Evidence from Systematic Reviews and Meta-Analyses in Cannabis Research](https://cedclinic.com/cannabinoid-formulations-anxiety-disorders-evidence-reviews/) A comprehensive review of cannabinoids' effects on anxiety and Tourette's syndrome, highlighting clinical evidence and research findings. [Read More](https://cedclinic.com/cannabinoid-formulations-anxiety-disorders-evidence-reviews/) [Lighting Science and Advanced Cultivation to Take Center Stage at Dutch Cannabis Research Tour](https://cedclinic.com/lighting-science-advanced-cultivation-dutch-cannabis-research/) Explore how lighting science and cultivation techniques impact cannabis chemical profiles and quality in cutting-edge research. [Discover Insights](https://cedclinic.com/lighting-science-advanced-cultivation-dutch-cannabis-research/) [Study Finds Minor Cannabinoids Show Distinct Effects on Pain-Sensing Neurons](https://cedclinic.com/minor-cannabinoids-pain-management-research/) New research reveals how minor cannabinoids influence pain pathways, contributing to the understanding of cannabis chemical complexity. [Learn More](https://cedclinic.com/minor-cannabinoids-pain-management-research/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).